FGFR4 and cancer: In contrast to the normal production and action of FGF19 as an endocrine hormone, FGF19 is overexpressed and co-expressed with FGFR4 in various cancers of liver, breast, lung, bladder, head, and neck7–10, indicating FGF19 as a driver oncogene.